Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  199.34
-8.20 (-3.95%)
AAPL  248.80
-4.09 (-1.62%)
AMD  201.99
-1.78 (-0.87%)
BAC  46.97
-1.27 (-2.63%)
GOOG  273.76
-6.98 (-2.49%)
META  525.72
-21.82 (-3.99%)
MSFT  356.77
-9.20 (-2.51%)
NVDA  167.52
-3.72 (-2.17%)
ORCL  139.66
-3.15 (-2.21%)
TSLA  361.83
-10.28 (-2.76%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.